Prison time for federal employee in cancer scam
santamariatimes.com     May 11, 2008            

SACRAMENTO - A former federal worker has been sentenced to a year in prison for vacation fraud. ... Robert Joseph Thom persuaded federal employees nationwide to donate nearly 1,000 hours of their own paid leave so he could take time off for fictitious cancer treatments.... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

Cancer patient demands answers over radiation bungle (ABC)

yahoo.com     3 hrs ago   3 related          

A former Royal Adelaide Hospital cancer patient has demanded answers as to why he may have been incorrectly treated. One of four radiotherapy machines at the hospital was found to have given patients lower doses of radiation...                

comments

                   

Cancer Scare: How to Tell if You Have a Radioactive Countertop

nationalledger.com     3 hrs ago          

Forget the cell phone cancer scare, now there may be reason to worry about what is on your kitchen countertop. It's not only the food (no Mexican jalapeños the FDA says) it now might be that your granite countertop is...                

comments

                   

Monitoring serial changes in circulating human breast cancer cells in murine xenograft models.

biowizard.com     3 hrs ago          

Breast Oncology Program, Comprehensive Cancer Center, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0942, USA. Circulating tumor cells (CTC) are emerging as a powerful...                

comments

                   

Nexavar Study Demonstrates Significant Improvement In Overall Survival In Patients With Liver Cancer

medicalnewstoday.com     3 hrs ago          

Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. announced that The New England Journal of Medicine published landmark results of a Nexavar study in liver cancer. The data of the Phase III trial showed that Nexavar®...                

comments